fda pulls semaglutide Hims & Hers stock falls 25% as curtails compounded GLP-1s Semaglutide FDA Approval vs Compounded

Why GLP-1 drugs and menopause could create a perfect storm for bone loss Bone loss can lead to osteoporosis, which causes bones to become porous, weaker and brittle, making them more likely to break, often in the hips, spine and wrists

Coverage context No Canadian provincial health plan covers Wegovy when prescribed for weight management as of January 2026

GLP-1 receptor agonists like semaglutide and tirzepatide work differently

Suzanne Robbs Journey: From Frustration To Freedom Suzanne Robb, a longtime fitness veteran and Alloys COO, opened up about her personal journey with weight loss drugs

Learn more: GLP-1 Plans 5